Gilead Sciences (GILD) PT Lowered to $62 at Atlantic Equities
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $81.44 --0%
Rating Summary:
25 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 5 | New: 18
Rating Summary:
25 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 5 | New: 18
Join SI Premium – FREE
Atlantic Equities analyst Steve Chesney lowered the price target on Gilead Sciences (NASDAQ: GILD) to $62.00 (from $65.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Gilead Sciences (GILD)
- Viridian Therapeutic (VRDN) PT Raised to $38 at Needham
- Bayerische Motoren Werke AG (BMW:GR) (BMWYY) PT Lowered to EUR85 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
